Linkage to Care - Part I

Completed

• Conditions: HIV

• Registration Number: NCT00703040
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

This first phase of a two-phase study involves three components:

1. Review of existing linkage-to-care protocols and sources of referrals for care;

2. Semi-structured telephone or face-to-face interviews with a minimum of two personnel per site who are associated with linkage to medical care. (Preference will be given to personnel with direct experience in linkage to care); and

3. Structured observations of referral sessions.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-03
• Study First Submitted: 2008-06-20
• Study First Submitted QC: 2008-06-20
• Study First Posted: 2008-06-23
• Primary Completion: 2010-03
• Study Completion: 2010-03
• Status Verified: 2016-02
• Last Update Submitted: 2017-02-27
• Last Update Posted: 2017-02-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• Component 1: Documents identified by clinical site personnel as pertaining to post-test counseling, linkage to care, or standard operating procedures addressing post-test counseling and linkage to care.
• Component 2: Persons employed by one of the AMTUs or an identified linkage-to-care partner and work as clinical staff or a case-manager or is a person familiar to linkage to care; or persons involved in posttest counseling and linkage-to-care processes. Clinical staff and case managers are chosen based on direct experience in the assistance of HIV seropositive youth obtaining medical care. This definition includes, but is not limited to, physicians, nurses, psychologists, social workers, and case managers (who may have diverse professional backgrounds).
• Component 3: All AMTU sites will be included.

Read More

Exclusion Criteria

• Component 1: No a priori exclusions.
• Component 2: No a priori exclusions.
• Component 3: No a priori exclusions.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Describe and evaluate community screening standards and practices.	1 year
Describe and evaluate referral and intake protocols.	1 year
Describe and evaluate care adherence support (including support from both clinical and non-clinical sources).	1 year
Describe and evaluate the relationships of screening venues with care-providing venues.	1 year

Trial Locations

Locations (7)

Children's National Medical Center; 🇺🇸 Washington, District of Columbia, United States

Mount Sinai Medical Center; 🇺🇸 Manhattan, New York, United States

Childrens Diagnostic&Treatment Center; 🇺🇸 Fort Lauderdale, Florida, United States

University of Miami School of Medicine; 🇺🇸 Miami, Florida, United States

St. Jude Childrens Research Hospital; 🇺🇸 Memphis, Tennessee, United States

Children's Hospital of Philadelphia; 🇺🇸 Philadelphia, Pennsylvania, United States

Montefiore Medical Center; 🇺🇸 Bronx, New York, United States